Sarcoglycan-sarcospan complex (SG-SSPN)

The Sarcoglycan-sarcospan (SG-SSPN) complex is a multi-subunit transmembrane assembly essential for maintaining the structural integrity of the sarcolemma in striated muscle (UniProt, 2023). It is a core component of the Dystrophin-Glycoprotein Complex (DGC), consisting of alpha-, beta-, gamma-, and delta-sarcoglycans along with the tetraspanin protein sarcospan (PubMed, PMID: 10678171). The complex functions as a mechanical linker between the extracellular matrix and the intracellular cytoskeleton, specifically interacting with microtubules and phospholipids to regulate membrane tension and signaling (PubMed, PMID: 22492360). Mutations in the sarcoglycan subunits cause autosomal recessive Limb-Girdle Muscular Dystrophies (LGMD2C-F), characterized by progressive muscle wasting (NIH, 2022). In Duchenne Muscular Dystrophy (DMD), the SG-SSPN complex is often destabilized and lost from the membrane. Current therapeutic approaches include gene replacement therapies using adeno-associated virus (AAV) vectors, such as SRP-9003, to deliver functional sarcoglycan genes and research into small molecules that can upregulate sarcospan to compensate for the loss of other DGC components (Sarepta Therapeutics, 2023).

Other names

Sarcoglycan-sarcospan subcomplexSG-SSPN complexDystrophin-associated glycoprotein complex (DGC) subcomplexSarcoglycan complex

Gene replacement therapy to restore functional protein expression and stabilize the sarcolemma.